Declining Coronary Heart Disease Mortality in Iceland: Contribution by Incidence, Recurrence and Case Fatality Rate
Autor: | Uggi Agnarsson, Ingibjörg Stefánsdóttir, Nikulás Sigfússon, Inga Ingibjörg Gudmundsdottir, Helgi Sigvaldason, Gunnar Sigurdsson, Vilmundur Gudnason |
---|---|
Rok vydání: | 2002 |
Předmět: |
Adult
Male medicine.medical_specialty Iceland Coronary Disease Pilot Projects Autopsy Medical Records Recurrence Epidemiology Case fatality rate Computer Graphics medicine Humans Myocardial infarction Survival rate Aged Retrospective Studies business.industry Incidence Mortality rate Incidence (epidemiology) Retrospective cohort study Middle Aged medicine.disease Surgery Survival Rate Regression Analysis Female Cardiology and Cardiovascular Medicine business Demography |
Zdroj: | Scandinavian Cardiovascular Journal. 36:337-341 |
ISSN: | 1651-2006 1401-7431 |
Popis: | To analyse to what extent the recent decline in coronary heart disease mortality in Iceland is due to changes in incidence, recurrence and case fatality rates.A countrywide registration of myocardial infarction (MI) in people aged 25-74 was performed in Iceland during 1981-1999 according to the MONICA protocol. Possible cases were found by review of all hospital discharge records, autopsy records and death certificates.MI death rate declined by 63% in males and 51% in females, most in the youngest age groups in men (86%) and least in the oldest (49%). In women there was not a significant difference in age groups. Overall the age-adjusted reduction in MI death rate was 55.4% in both sexes combined; of this 23.1% was due to incidence reduction, 22.8% to recurrence reduction and 11.6% to case fatality reduction. In the youngest age groups the decline in incidence contributed most to the decline in MI death rate (62% in men and 71% in women), but thereafter the decline in case fatality in men. In the older age groups decline in recurrence rate has greater weight.The recent decline in MI mortality under the age of 75 years in Iceland is due to reduction in incidence and recurrence rate by about 40% each and to reduction in case fatality by 20%. |
Databáze: | OpenAIRE |
Externí odkaz: |